Business
Press Release Oct 30 2025
Cipla Limited has informed the Exchange regarding a press release dated October 30, 2025, titled "Q2 FY26 Results".
About this update from Cipla Ltd
Cipla Limited has informed the Exchange regarding a press release dated October 30, 2025, titled "Q2 FY26 Results". View Attachment
More from Cipla Ltd
Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda in the US
September 4, 2026
Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab) in...
September 3, 2026